Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- INDSWFTLTD.NSE
- Price
- 13.03
- Stock movement down
- -0.08 (-0.61%)
- Company name
- Ind-Swift Limited
- Exchange
- (NSE ,
- Currency
- INR )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Market cap
- 705.77M
- Ent value
- 13.46B
- Price/Sales
- 0.14
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- 1.28
- Forward P/E
- -
- PEG
- -
- EPS growth
- -8.46%
- 1 year return
- -54.12%
- 3 year return
- 5.49%
- 5 year return
- 44.06%
- 10 year return
- 8.71%
Last updated: 2025-04-12
DIVIDENDS
INDSWFTLTD.NSE does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 1.28 |
| Price to OCF | 5.21 |
| Price to FCF | 5.21 |
| Price to EBITDA | 15.73 |
| EV to EBITDA | 299.90 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 0.14 |
| Price to Book | - |
| EV to Sales | 2.76 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 54.16M |
| EPS (TTM) | 10.15 |
| FCF per share (TTM) | 2.50 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 4.88B |
| Gross profit (TTM) | 1.46B |
| Operating income (TTM) | 355.37M |
| Net income (TTM) | 549.25M |
| EPS (TTM) | 10.15 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 29.97% |
| Operating margin (TTM) | 7.28% |
| Profit margin (TTM) | 11.26% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 688.45M |
| Net receivables | 0.00 |
| Total current assets | 3.84B |
| Goodwill | 0.00 |
| Intangible assets | 104.17M |
| Property, plant and equipment | 0.00 |
| Total assets | 6.86B |
| Accounts payable | 2.31B |
| Short/Current long term debt | 10.23B |
| Total current liabilities | 3.08B |
| Total liabilities | 13.44B |
| Shareholder's equity | -6.58B |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 135.53M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | 135.53M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | 8.01% |
| Return on Invested Capital | -8.38% |
| Cash Return on Invested Capital | -2.07% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 13.69 |
| Daily high | 13.69 |
| Daily low | 12.99 |
| Daily Volume | 15K |
| All-time high | 84.85 |
| 1y analyst estimate | - |
| Beta | -0.11 |
| EPS (TTM) | 10.15 |
| Dividend per share | - |
| Ex-div date | 21 Sep 2011 |
| Next earnings date | 12 May 2025 |
Downside potential
Loading...
Downside potential data
| INDSWFTLTD.NSE | S&P500 | |
| Current price drop from All-time high | -84.64% | -12.89% |
| Highest price drop | -97.76% | -56.47% |
| Date of highest drop | 26 May 2020 | 9 Mar 2009 |
| Avg drop from high | -77.04% | -11.07% |
| Avg time to new high | 338 days | 12 days |
| Max time to new high | 4851 days | 1805 days |
COMPANY DETAILS
Marketcap
705.77M
Marketcap category
Small-cap
Description
Ind-Swift Limited develops pharmaceutical formulations, finished goods dosages, active pharmaceutical ingredients, and herbal products in India. The company offers medicines for various therapeutic segments, such as ENT, dentistry, anti-infective, cardio-diabetic, and orthopedic therapies under the Zoxiclav, Glypar, Olmiswif, Telhim, Ozodom-DSR, Cefextil-O, Swiclo-Sp, Swifix-O, Swifix 200, Stemin, and Stemin Forte names. It also offers medicines for various therapeutic comprising gynaecology, pediatrics, dermatology, and other generic medicines under the Anin, Suprox, Cozy, Distone, and Oliade name. In addition, the company provides antibiotic, anti-cold, nutraceuticals, anti-diarrhoeal, anti-malarial, anti-depressants, cardiology, diabetology, anti-depressant, anti-allergic, anti- infective, neurology, and oncology. Ind-Swift Limited provides Ayurvedic products, as well as contract research and manufacturing services. The company exports its products, as well as licenses its products to Europe, Australia, Canada, South Africa, and Russia. Swift Limited was founded in 1983 and is based in Chandigarh, India.
Employees
1054
Website
Investor relations
-
SEC filings
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found